Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics
GET POWR RATINGS... FREE!
SPPI Stock Summary
- The ratio of debt to operating expenses for Spectrum Pharmaceuticals Inc is higher than it is for about merely 0.37% of US stocks.
- With a year-over-year growth in debt of -100%, Spectrum Pharmaceuticals Inc's debt growth rate surpasses only 0% of about US stocks.
- As for revenue growth, note that SPPI's revenue has grown -72.9% over the past 12 months; that beats the revenue growth of merely 1.74% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Spectrum Pharmaceuticals Inc, a group of peers worth examining would be RMBS, QUIK, XERS, PDFS, and CTIC.
- SPPI's SEC filings can be seen here. And to visit Spectrum Pharmaceuticals Inc's official web site, go to www.sppirx.com.
SPPI Stock Price Chart Interactive Chart >
SPPI Price/Volume Stats
| Current price | $2.37 | 52-week high | $5.24 |
| Prev. close | $2.40 | 52-week low | $2.14 |
| Day low | $2.34 | Volume | 1,425,900 |
| Day high | $2.41 | Avg. volume | 2,734,030 |
| 50-day MA | $2.61 | Dividend yield | N/A |
| 200-day MA | $3.36 | Market Cap | 388.85M |
Spectrum Pharmaceuticals, Inc. (SPPI) Company Bio
Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. The company was founded in 1987 and is based in Henderson, Nevada.
Latest SPPI News From Around the Web
Below are the latest news stories about Spectrum Pharmaceuticals Inc that investors may wish to consider to help them evaluate SPPI as an investment opportunity.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPINew York, New York--(Newsfile Corp. - September 23, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. ("Spectrum") (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Nevada. To get more information ... |
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPINew York, New York--(Newsfile Corp. - September 23, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between December 27, 2018 and August 5, 2021, inclusive (the "Class Period"), of the important November 1, 2021 lead plaintiff deadline.SO WHAT: If you purchased Spectrum Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out ... |
LAWSUITS FILED AGAINST PHG, ANVS and SPPI - Jakubowitz Law Pursues Shareholders ClaimsNEW YORK, NY / ACCESSWIRE / September 23, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. |
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. (SPPI)Law Offices of Howard G. Smith reminds investors of the upcoming November 1, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) securities between December 27, 2018 and August 5, 2021, inclusive (the "Class Period"). |
SPPI INVESTOR CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.New York, New York--(Newsfile Corp. - September 23, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) from December 27, 2018 through August 5, 2021 (the "Class Period"). The lawsuit filed ... |
SPPI Price Returns
| 1-mo | 0.85% |
| 3-mo | -39.07% |
| 6-mo | -23.55% |
| 1-year | -44.95% |
| 3-year | -85.71% |
| 5-year | -49.14% |
| YTD | -30.50% |
| 2020 | -6.32% |
| 2019 | -58.40% |
| 2018 | -53.83% |
| 2017 | 327.77% |
| 2016 | -26.53% |
Continue Researching SPPI
Want to do more research on Spectrum Pharmaceuticals Inc's stock and its price? Try the links below:Spectrum Pharmaceuticals Inc (SPPI) Stock Price | Nasdaq
Spectrum Pharmaceuticals Inc (SPPI) Stock Quote, History and News - Yahoo Finance
Spectrum Pharmaceuticals Inc (SPPI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...